Aspirin/meprobamate
 | This article needs additional citations for verification. (June 2016) |
| Combination of | |
|---|---|
| Aspirin | NSAID |
| Meprobamate | Anxiolytic |
| Clinical data | |
| Trade names | Equagesic |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
Aspirin/meprobamate (trade name Equagesic /ˌɛkwəˈdʒiːzɪk/) is a combination drug indicated for short-term pain treatment accompanied by tension or anxiety in patients with musculoskeletal disorders or tension headache.
Combinations
There also appears to be a combination with ethoheptazine, an opioid analgesic.[1]
Problems
Equagesic was discontinued in the United States, possibly because of its toxic profile and more adequate drugs available. Specifically, meprobamate is more toxic than benzodiazepines, which are also useful as a muscle relaxant.
References
- ^ NetDoctor.co.uk - Information about drugs for Patients Archived September 27, 2007, at the Wayback Machine
 | This analgesic-related article is a stub. You can help Wikipedia by expanding it. |